Publications

FDA says it wants individualized medicines. Can we get there?

Quoted, Chemical & Engineering News

Shareholder Claire Davies explains that while the FDA’s new pathway could benefit rare disease patients, uncertainty remains about the evidence required to demonstrate a treatment’s effectiveness.